Major Study Shows That Lescol(R) XL, A Statin From Novartis, Improves Post-operative Cardiac Outcomes In Patients Undergoing Vascular Surgery
Links shared publicly online about this topic.
- 1,769total visits
Major Study Shows That Lescol(R) XL, A Statin From Novartis, Improves Post-operative Cardiac Outcomes In Patients Undergoing Vascular Surgery
Patients undergoing vascular surgery treated perioperatively with lescol® xl (fluvastatin sodium extended-release tablets) showed a significant improvement in postoperative cardiac outcome wit
View full resource at medicalnewstoday.com
Tags: Heart, Cholesterol Medication, Mineral, Sodium, Lescol, Novartis, Surgery, Vascular Surgery
Most Recently Shared on September 6, 2009 at 10:28 am By:
MedicalNewsToday: Major Study Shows That Lescol(R) XL, A Statin From Novartis, Improves: http://bit.ly/Zwo4f Full http://bit.ly/xaCPT
Also Shared By:
Advertisement
MNT Cardiovascular
@mnt_cardiovasc
Major Study Shows That Lescol(R) XL, A Statin From Novartis, Improves Post-operative Cardiac Outcomes In Patient.. http://bit.ly/RIdDC
1 year ago...